Soyasaponin B-II CAS 55319-36-3

What is Soyasaponin B-II CAS 55319-36-3?

Soyasaponin B-II CAS 55319-36-3 is one of the group B soyasaponins extracted from soybeans and other plant sources, representing a class of complex glycosides with amphiphilic characteristics that have attracted considerable scientific interest due to their diverse biological effects; although not approved for clinical or food use, it is used extensively in in vitro and in vivo research to investigate antiviral, anti-inflammatory, hepatoprotective, and other bioactivities, and to explore mechanisms involving immune modulation, virus replication inhibition, and inflammasome regulation.

Specification

Feature

• Natural Occurrence: Soyasaponin B-II is a plant-derived triterpenoid saponin found in soybeans (Glycine max) and related legumes, reflecting its status as a secondary metabolite in widely cultivated food crops.
• Research Material: It is supplied as a high-purity powder exclusively for scientific research applications, with explicit use limitations for laboratory and pharmaceutical investigation rather than human consumption.
• Bioactivity Focus: Researchers study Soyasaponin B-II for its interactions with biological targets relevant to virus replication and inflammatory pathways, making it a model compound in signaling and immunology research.
• Analytical Standard: Due to well-characterized identity and purity (>98%), it is used as a standard or reference material in chromatographic and bioanalytical assays studying plant saponins.
• Structural Class: It belongs to the triterpenoid saponin class of natural products, a structurally diverse group of glycosides with both hydrophilic sugar and hydrophobic aglycone components, of interest in natural-product chemistry.

Application

• Antiviral Research: Soyasaponin B-II is used in biological research to evaluate inhibitory effects on the replication of viruses including HSV-1, HCMV, influenza, and HIV-1 in cell-based assays.
• Inflammation Studies: It is applied in mechanistic studies of inflammatory pathways, notably as an inhibitor of YB-1 phosphorylation and NLRP3 inflammasome priming in immune cells and animal models.
• Hepatoprotective Models: In vivo research uses Soyasaponin B-II to investigate potential protection against chemically induced acute liver injury and innate immune responses.
• Pharmacological Screening: The compound is included in screening libraries for evaluating biological activity in drug discovery programs targeting immune modulation, viral infection pathways, or metabolic regulation.
• Plant Metabolite Analysis: It serves as an analytical target in plant metabolomics and phytochemical profiling to study soybean composition and saponin distribution in agricultural and food science research.

Packaging

Mikem offers flexible packaging options, including 25 kg of fiber drums for liquid products and 15–25 kg PP/PE bags for powder products, all customizable to meet your specific needs.